Multiple Sclerosis Clinical Trials in Los Angeles

Showing 481-500 of 571 trials

Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma

NCT00183794

This study is for patients with advanced ovarian cancer that has reappeared after treatment with conventional therapy. The purpose of this study is to determine if the combination of docetaxel and gemcitabine will be effective in reducing or eliminating the tumor(s) in patients with ovarian cancer. Docetaxel is approved by the Food and Drug Administration (FDA) for the treatment of breast and lung cancer; gemcitabine is approved by the FDA for the treatment of pancreatic and lung cancer. Neither docetaxel nor gemcitabine are approved for the treatment of ovarian cancer. Both drugs have been shown to decrease the size of ovarian cancer tumors.

Ovarian CarcinomaPeritoneal Neoplasms

University of Southern California20 participantsStarted Nov 2002

Los Angeles, California, United States

COMPLETEDPhase 3< 1 mile

Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

NCT00638690

This is a phase 3 study to compare the clinical benefit of abiraterone acetate plus prednisone with placebo plus prednisone in patients with metastatic castration-resistant prostate cancer (CRPC) who have failed one or two chemotherapy regimens. At least one of the previous chemotherapies must have contained docetaxel.

Prostatic Neoplasms

Cougar Biotechnology, Inc.1,195 participantsStarted May 2008

Birmingham, Alabama, United States • Tucson, Arizona, United States • Beverly Hills, California, United States +124 more locations

Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma

Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Multiple Sclerosis Trials in Other Cities

MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.

Ultrasound Elastography of Breast Lesions

An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy

Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy

Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas

Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal Women

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer

PRISM Registry: Pseudobulbar Affect Registry Series

An Efficacy, Safety and Tolerability Study of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administered Daily by Subcutaneous (SC) Injection in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)

The Evaluation of Infant Formulas Fed to Infants With Common Feeding Problems

Treatment With Pazopanib for Neoadjuvant Breast Cancer

Bevacizumab in Treating Patients With Myelodysplastic Syndrome

Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer

Treatment Interruption of Natalizumab

An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast Cancer

A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT

Other Conditions in Los Angeles